OpenURL Connection Search

Select item for more details and to access through your institution.

Association between Geriatric Impairments and Quality of Life in Older Adults with Lymphoma on Oral Targeted Therapies: A One‐Year Prospective Study.
Published in:
Hematological Oncology, 2023, v. 41, p. 602, doi. 10.1002/hon.3164_451
By:
- Torka, P.;
- Akhtar, O.;
- Kaijar, T.;
- Wang, K.;
- Attwood, K.;
- Carozza, D.;
- Bouchard, E.;
- Ghione, P.;
- Cortese, M.;
- Wildes, T.;
- Hernandez‐Ilizaliturri, F.
Publication type:
Article
The prognostic value of progressing within 24 months of frontline chemoimmunotherapy (POD24) in relapsed/refractory (R/R) follicular lymphoma (FL)—a SCHOLAR‐5 analysis.
Published in:
Hematological Oncology, 2023, v. 41, p. 376, doi. 10.1002/hon.3164_272
By:
- Patel, A. R.;
- Limbrick‐Oldfield, E. H.;
- Kanters, S.;
- Ray, M. D.;
- Best, T.;
- Ghione, P.;
- Neelapu, S. S.;
- Gribben, J. G.;
- Beygi, S.;
- Bobillo, S.
Publication type:
Article
PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, p. 351, doi. 10.1002/hon.3164_253
By:
- Moskowitz, A.;
- Savage, K.;
- Feldman, T.;
- Ganesan, N.;
- Hancock, H.;
- Davey, T.;
- Perez, L.;
- Santarosa, A.;
- Subzwari, S.;
- Capadona, C.;
- Yang, C.;
- Galasso, N.;
- David, K.;
- Epstein‐Peterson, Z.;
- Khan, N.;
- Kumar, A.;
- Hamlin, P.;
- Ghione, P.;
- Lue, J.;
- Straus, D.
Publication type:
Article
BRCA1/2 MUTATIONS IMPACT ON THE DEVELOPMENT OF BREAST IMPLANT‐ASSOCIATED LYMPHOMA (BIA‐ALCL) IN WOMEN WITH BREAST CANCER RECONSTRUCTED WITH TEXTURED BREAST IMPLANTS.
Published in:
Hematological Oncology, 2023, v. 41, p. 193, doi. 10.1002/hon.3163_124
By:
- Ghione, P.;
- Arcila, M.;
- Joseph, V.;
- Dogan, A.;
- Cordeiro, P.;
- Salles, G.;
- de Jong, D.;
- Horwitz, S.;
- Mandelker, D.;
- van Leeuwen, F.
Publication type:
Article
PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 161, doi. 10.1002/hon.3163_107
By:
- Torka, P.;
- Feldman, T.;
- Savage, K.;
- Ganesan, N.;
- Hancock, H.;
- Davey, T.;
- Perez, L.;
- Santarosa, A.;
- Subzwari, S.;
- Capadona, C.;
- Yang, C.;
- Galasso, N.;
- David, K.;
- Epstein‐Peterson, Z.;
- Khan, N.;
- Kumar, A.;
- Hamlin, P.;
- Ghione, P.;
- Lue, J.;
- Straus, D.
Publication type:
Article
A PHASE 1 STUDY OF CARFILZOMIB WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (C‐RICE) IN TRANSPLANT‐ELIGIBLE RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.83_2881
By:
- Torka, P.;
- Groman, A.;
- Wong, J.;
- Baysal, B.;
- Nichols, J.;
- Kader, A.;
- Mavis, C.;
- Jani Sait, S.;
- Block, A.;
- Przespolewski, E.;
- Mohr, A.;
- Lund, I.;
- McWhite, K.;
- Kostrewa, J.;
- DeMarco, J.;
- Johnson, M.;
- Darrall, A.;
- Thomas, R.‐N.;
- Sundaram, S.;
- Ghione, P.
Publication type:
Article
OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL SCHOLAR‐5 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.26_2880
By:
- Ghione, P.;
- Ghesquieres, H.;
- Bobillo, S.;
- Patel, A. R.;
- Kanters, S.;
- Deighton, K.;
- Dong, H.;
- Yang, Y.;
- Ma, L.;
- Limbrick‐Oldfield, E. H.;
- Thornton Snider, J.;
- Wade, S. W.;
- Riberio, M. T.;
- Sudhindra, A.;
- Radford, J.;
- Palomba, M. L.;
- Gribben, J.
Publication type:
Article
RNA SEQUENCING REVEALS DIFFERENT GENE EXPRESSION IN MALE VERSUS FEMALE DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.14_2880
By:
- Ghione, P;
- Cortes Gomez, E;
- Torka, P;
- Sundaram, S;
- Mavis, C;
- Tabbo', F;
- Gu, J;
- Cacciapuoti, M. T;
- Yoffe, L;
- Wang, J;
- Hernandez‐Ilizaliturri, F;
- Inghirami, G
Publication type:
Article
RISK OF BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA‐ALCL) IN A COHORT OF 3546 WOMEN PROSPECTIVELY FOLLOWED AFTER RECEIVING TEXTURED BREAST IMPLANTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 97, doi. 10.1002/hon.62_2629
By:
- Ghione, P.;
- Cordeiro, P.G.;
- Ni, A.;
- Hu, Q.;
- Ganesan, N.;
- Galasso, N.;
- Dogan, A.;
- Horwitz, S.M.
Publication type:
Article
THE NONCODING RNA GECPAR IS INVOLVED IN WNT SIGNALING AND HAS TUMOR‐SUPPRESSOR ACTIVITY IN DIFFUSE LARGE B CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 77, doi. 10.1002/hon.46_2629
By:
- Napoli, S.;
- Cascione, L.;
- Rinaldi, A.;
- Sartori, G.;
- Forcato, M.;
- Bicciato, S.;
- Chiappella, A.;
- Ghione, P.;
- Elemento, O.;
- Inghirami, G.;
- Bertoni, F.
Publication type:
Article
TREATMENT AND OUTCOMES OF PATIENTS WITH NK/T‐CELL LYMPHOMA TREATED WITH MODIFIED (m)SMILE AND INTENSITY‐MODULATED RADIOTHERAPY (IMRT), A SINGLE CENTER EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 477, doi. 10.1002/hon.156_2631
By:
- Ghione, P.;
- Qi, S.;
- Imber, B.S.;
- Venkatraman, S.;
- Moskowitz, A.;
- Galasso, N.;
- Lunning, M.;
- Straus, D.;
- Sauter, C.;
- Dahi, P.;
- Dogan, A.;
- Yahalom, J.;
- Horwitz, S.M.
Publication type:
Article
RISK OF BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA‐ALCL) IN A COHORT OF 3546 WOMEN PROSPECTIVELY FOLLOWED AFTER RECEIVING TEXTURED BREAST IMPLANTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 97, doi. 10.1002/hon.62_2629
By:
- Ghione, P.;
- Cordeiro, P.G.;
- Ni, A.;
- Hu, Q.;
- Ganesan, N.;
- Galasso, N.;
- Dogan, A.;
- Horwitz, S.M.
Publication type:
Article
THE NONCODING RNA GECPAR IS INVOLVED IN WNT SIGNALING AND HAS TUMOR‐SUPPRESSOR ACTIVITY IN DIFFUSE LARGE B CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 77, doi. 10.1002/hon.46_2629
By:
- Napoli, S.;
- Cascione, L.;
- Rinaldi, A.;
- Sartori, G.;
- Forcato, M.;
- Bicciato, S.;
- Chiappella, A.;
- Ghione, P.;
- Elemento, O.;
- Inghirami, G.;
- Bertoni, F.
Publication type:
Article
TREATMENT AND OUTCOMES OF PATIENTS WITH NK/T‐CELL LYMPHOMA TREATED WITH MODIFIED (m)SMILE AND INTENSITY‐MODULATED RADIOTHERAPY (IMRT), A SINGLE CENTER EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 477, doi. 10.1002/hon.156_2631
By:
- Ghione, P.;
- Qi, S.;
- Imber, B.S.;
- Venkatraman, S.;
- Moskowitz, A.;
- Galasso, N.;
- Lunning, M.;
- Straus, D.;
- Sauter, C.;
- Dahi, P.;
- Dogan, A.;
- Yahalom, J.;
- Horwitz, S.M.
Publication type:
Article
Retrospective analysis on R-DHAP/OX and ASCT as salvage treatment for relapsed/refractory high-risk follicular lymphoma.
Published in:
Hematological Oncology, 2017, v. 35, p. 364, doi. 10.1002/hon.2439_119
By:
- Ghione, P.;
- Cavallo, F.;
- Visco, C.;
- Chen, Z.;
- Nicolosi, M.;
- Castellino, A.;
- Tisi, M.C.;
- Dogliotti, I.;
- Boccadoro, M.;
- Leonard, J.P.;
- Vitolo, U.;
- Martin, P.
Publication type:
Article
KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH-DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL.
Published in:
Hematological Oncology, 2017, v. 35, p. 94, doi. 10.1002/hon.2437_83
By:
- Ferrero, S.;
- Rossi, D.;
- Bruscaggin, A.;
- Evangelista, A.;
- Di Rocco, A.;
- Spina, V.;
- Stefoni, V.;
- Ghione, P.;
- Barbero, D.;
- Monitillo, L.;
- Gomes Da Silva, M.;
- Santoro, A.;
- Molinari, A.;
- Ferreri, A.;
- Piccin, A.;
- Cortelazzo, S.;
- Ladetto, M.;
- Gaidano, G.
Publication type:
Article

Found: 16